Background Stroke is a leading cause of mortality and disability around the world. It is responsible for 10% of all fatalities and about 5% of all disabilities. Risk factors include age, hypertension (HTN), dyslipidemia, and atrial fibrillation. The incidence of acute ischemic stroke (AIS) is increasing among young adults compared to older ones. It has a direct impact on their quality of life and working activities while also burdening the healthcare system. Aim The aim of this study is to investigate the possible risk factors for ischemic stroke in patients who are under 50 years old. Methods This is a single-center retrospective record review of patients with ischemic stroke from 2010 to 2022. Eighty patients who had an ischemic stroke at an age below 50 were included in the analysis. Patients above or equal to 50 years old who had ischemic stroke and all patients with hemorrhagic stroke were excluded. Baseline characteristics, length of hospitalization, and in-hospital mortality were compared with different comorbidities. Results The mean age was 36.65 among males and females who had an ischemic stroke. 56.8% of them were non-Saudi, while 43.2% were Saudis. Diabetes, hypertension, and dyslipidemia were among the most frequent comorbidities among patients who had ischemic stroke, with a percentage of 82.7%. Other comorbidities, such as autoimmune disease, thrombophilia, and heart failure, were present. Conclusion There are different comorbidities found in patients who have had an ischemic stroke and are under 50 years old. However, diabetes and hypertension remain the most common risk factors.
Background: Te evaluate the outcomes of Endovascular thrombectomy (EVT) -treated AIS patients in Jeddah, Saudi Arabia, and explores predictors of functional recovery. Endovascular thrombectomy (EVT) is the standard of care for acute ischemic stroke (AIS), though patient outcomes can vary based on regional and clinical factors. Method: A retrospective cohort study was conducted using medical records from King Abdulaziz University Hospital (KAUH) and King Fahad Hospital Jeddah (KFHJ), including AIS patients treated with EVT between January 2020 and July 2024. Neurological status was assessed using the NIH Stroke Scale (NIHSS), and clinical outcomes were evaluated with the modified Rankin Scale (mRS) at 90 days, where scores of 0–2 indicated good outcomes. Data on demographics, treatment times, recanalization success, and peri-procedural complications were collected and analyzed. Results: A total of 219 patients were included. Mean NIHSS scores on admission were similar across centers (14.6 ± 5 at KAUH vs. 15.5 ± 5.1 at KFHJ), while mRS scores at 90 days were slightly better at KAUH. The average time from last known well to hospital arrival was approximately 231 minutes across both centers. Door-to-puncture times were shorter at KFHJ (87.7 ± 61.2 minutes) compared to KAUH (114 ± 48.2 minutes). Successful recanalization (TICI 3) was achieved in 76.7% of cases, with higher rates at KAUH (87%) than KFHJ (72.1%). Functional independence (mRS 0–2) at 90 days was achieved in 33.5% of patients and was associated with younger age (p=0.05) and lower baseline NIHSS scores (p<0.001). Conclusion: EVT is technically effective for AIS in the Saudi population, with recanalization rates comparable to global benchmarks. However, functional outcomes remain suboptimal due to delayed presentation, high rates of metabolic comorbidities, and post-procedural complications. Efforts to improve early stroke recognition, reduce pre-hospital delays—such as through the implementation of mobile stroke units—and control vascular risk factors are essential to improving patient outcomes.
Background: Multiple trials have evaluated the benefits of endovascular thrombectomy (EVT) in patients with large-core ischemic stroke. This study aimed to determine the efficacy and safety of EVT compared with medical management (MM) alone in patients with large ischemic core infarcts. Methods: This study was registered in PROSPERO (CRD420261360129). A comprehensive search of PubMed, Web of Science, and the Cochrane Library was conducted to identify all relevant studies published up to April 2026. Effect sizes were calculated as risk ratios (RRs) using random-effects or fixed-effects models, as appropriate. Study quality was assessed using the Cochrane Risk of Bias tool and the Newcastle–Ottawa Scale. Subgroup and sensitivity analyses were performed to explore heterogeneity and evaluate outcomes across different patient populations. Outcomes assessed included excellent functional independence (mRS 0–2) and favorable functional outcome (mRS 0–3) at 3 months, mean mRS at 3 and 12 months, symptomatic intracranial hemorrhage, and all-cause mortality at 3 and 12 months. Results: Nine eligible studies (5 randomized controlled trials [RCTs] and 4 cohort studies; total sample size = 2252) were included to evaluate the comparative efficacy and safety of EVT versus MM alone in patients with acute ischemic stroke (AIS) secondary to large vessel occlusion. Our pooled analysis demonstrated a significantly higher rate of achieving a modified Rankin Scale (mRS) score of 0–2 in the EVT group compared with the MM group (RR = 2.64, 95% CI [1.79–3.90], p < 0.00001). Similarly, the likelihood of achieving an mRS score of 0–3 was significantly greater with EVT than with MM (RR = 1.78, 95% CI [1.40–2.26], p < 0.00001). The mean mRS score at 3 months was also significantly lower in the EVT group (MD = −0.58, 95% CI [−0.77 to −0.39], p < 0.00001). Safety outcomes were comparable between groups, with no significant differences in the rates of symptomatic intracranial hemorrhage (sICH) (RR = 1.36, 95% CI [0.88–2.11], p = 0.17) or mortality (RR = 0.96, 95% CI [0.65, 1.42], p = 0.84, I2 = 75%). Conclusions: Our findings suggest that EVT is associated with improved functional outcomes compared with MM alone, particularly in evidence derived from RCTs, while maintaining an acceptable safety profile. Further high-quality RCTs are warranted to strengthen the evidence base and validate these findings.